India remains a highly attractive investment destination, thanks to its stable and rules-based economic environment bolstered by ongoing structural reforms.

The country’s healthcare sector presents a compelling opportunity, driven by a growing population, rising incomes, increasing healthcare awareness, and expanding health insurance coverage.

Reflecting this potential, Singapore’s sovereign wealth fund GIC has pledged an additional US$150 million to Asia Healthcare Holdings (AHH), a platform focused on single-specialty healthcare. This follows an initial investment of US$170 million in 2022, underscoring GIC’s strong confidence in AHH’s growth model and prospects.

Since its inception in 2016, AHH, backed by GIC and TPG, has invested approximately US$300 million across healthcare verticals, including oncology, mother and child care, urology and nephrology, and fertility. Its portfolio includes prominent names like Motherhood Hospitals, Nova IVF, and the Asian Institute of Nephrology & Urology (AINU).

Motherhood Hospitals is a leading network offering comprehensive services from pre-conception to pediatric care, with the largest neonatal intensive care unit (NICU) network in India. Nova IVF stands as a fertility solutions leader in South Asia, while AINU is recognized for its advanced robotic surgeries and nephrology expertise.

“Our strategy to build and grow single-specialty healthcare enterprises has addressed critical gaps in healthcare services in India,” says AHH executive chairman Vishal Bali. He credits AHH’s rapid rise to its strategic investments in technology and quality care, establishing market leadership across its businesses.

The additional funding will enable AHH to explore new specialties and further scale its existing portfolio. With GIC’s renewed support and TPG’s continued partnership, AHH is well-positioned to expand its footprint and make quality healthcare more accessible across India, cementing its role as a leader in the region’s evolving healthcare landscape.